Back to top

VRDN Maintained by Wedbush -- Price Target Raised to $43.00

VRDN Maintained by Wedbush -- Price Target Raised to $43.00

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Viridian Therapeutics, Inc. (VRDN)